The major research programs of the Division are:
- Molecular Oncology and Cancer Genetics
- Tumor Immunology and Inflammation
- Hematopoiesis and Bone Marrow/Stem Cell Transplantation
- Molecular Coagulation
- Clinical Pharmacology and Experimental Therapeutics
- Cancer Epidemiology and Prevention
The strengths of these research programs (laboratory and clinical) are reflected by the continued success of division faculty in attracting significant grant support, which totaled spending of $50.9M in FY10 (a 22% increase in direct plus indirect funding compared to the previous fiscal year due to the transfer of the SWOG DCP/CCOP Research Base grant) including $34.8M (a 34% increase from FY09) in direct funds received from federal sources (NIH, Department of Defense, and VAMC), and $9.2M received in direct funds from non-federal sources (a 3% decrease from FY09). Included in this funding portfolio, the division received $25.4M in NCI direct funds for the Southwest Oncology Group (SWOG); excluding this funding our FY09 spending was still an impressive 8% increase over FY09. $31.8M in new grant funding (total project funds) was awarding in FY10. As a measure of investigative productivity, total indirects per square foot of research space is $174, compared to the target of $110 per square foot..